Acute cocaine administration activates behavioral and neuroendocrine processes associated with the stress response. However, much less is known about the effects of chronic, long-term cocaine administration on neuroendocrine adaptations and individual vulnerability to stress. We hypothesized that chronic ‘binge’ cocaine administration may serve as a chronic pharmacological stressor leading to a hyperactivity of the stress-responsive hypothalamic-pituitary-adrenal (HPA) axis and alterations in its feedback mechanisms. In order to test this hypothesis, the effects of long-term (3 and 6 weeks) ‘binge’ pattern cocaine administration (3×15 mg/kg cocaine, i.p., daily, during the early phase of the light cycle) on body weight, adrenal gland weight, basal and stress-induced activity of the corticosterone (CORT) and basal plasma testosterone (T) levels were measured. Both 3 and 6 weeks ‘binge’ cocaine administration decreased body weight gain, increased the weight of adrenal glands and increased basal CORT levels. Plasma T levels were suppressed by both 3 and 6 weeks of cocaine treatment. No correlation was found between elevated CORT and low T levels at any time point. Neither chronic saline nor cocaine administration altered stress-induced CORT secretion. CORT levels 60 min following the restraint stress (recovery) were significantly lower than pre-stress basal levels after 3 and 6 weeks of cocaine, but not saline, administration. Moreover, initial individual differences in stress-induced CORT response, i.e. low and high responsivity to restraint prior to any saline or cocaine injections, were maintained in control rats but became diminished in cocaine-treated rats. These results indicate that chronic binge cocaine administration leads to sustained activation of the HPA axis and alters processes underlying individual vulnerability to stress.

Keywords:
Cocaine, Adrenal steroids, Stress, Corticotropin, Corticotropin-releasing hormone
1.
Moldow RL, Fischman AJ: Cocaine induced secretion of ACTH, β-endorphin, and corticosterone. Peptides 1987;456:819–822.
2.
Rivier C, Vale W: Cocaine stimulates adrenocorticotropin (ACTH) secretion through a corticotropin-releasing factor (CRF)-mediated mechanism. Brain Res 1987;422:403–406.
3.
Borowsky B and Kuhn CM: Monoamine mediation of cocaine-induced hypothalamo-pituitary-adrenal activation. J Pharmacol Exp Ther 1991;256:204–210.
4.
Sarnyai Z, Bíró, Penke B, Telegdy G: The cocaine-induced elevation of plasma corticosterone is mediated by endogenous corticotropin-releasing factor (CRF) in rats. Brain Res 1992;589:154–156.
5.
Sarnyai Z, Mello NK, Mendelson JH, Erös- Sarnyai M, Mercer G: Effects of cocaine on pulsatile activity of the hypothalamic-pituitary-adrenal axis in male rhesus monkeys: Behavioral and neuroendocrine correlates. J Pharmacol Exp Ther 1996;277:225–234.
6.
Mendelson JH, Teoh SK, Mello NK, Ellingboe J, Rhodes E: Acute effects of cocaine on plasma ACTH, luteinizing hormone and prolactin levels in cocaine-dependent men. J Pharmacol Exp Ther 1992;263:505–509.
7.
Teoh SK, Sarnyai Z, Mendelson JH, Mello NK, Springer SA, Sholar JW, Wapler M, Kuehnle JC, Gelles H: Cocaine effects on pulsatile secretion of ACTH in men. J Pharmacol Exp Ther 1994;270:1134–1138.
8.
Baumann MH, Gendron TM, Becketts KM, Henningfeld JE, Gorelick DA, Rothman RB: Effects of intravenous cocaine on plasma cortisol and prolactin in human cocaine abusers. Biol Psychiatry 1995;38:751–755.
9.
Kreek MJ: Medical safety and side effects of methadone in tolerant individuals. J Am Med Assoc 1973;223:665–668.
10.
Kreek MJ, Raghunath J, Plevy S, Hamer D, Schneider B, Hartman N: ACTH, cortisol and beta-endorphin response to metyrapone testing during chronic methadone maintainance treatment in humans. Neuropeptides 1984;5:277–278.
11.
Kreek MJ: Multiple drug abuse patterns and medical consequences; in Meltzer HY (ed); Psychopharmacology: The Third Generation of Progress. New York, Raven Press, 1987, pp 1597–1604.
12.
Kreek MJ: Rationale for maintenance pharmacotherapy of opiate dependence; in O’Brian CP, Jaffe JH (eds): Addictive States. New York, Raven Press, 1992, pp 205–230.
13.
Schluger J, Bodner G, Gunduz M, Ho A, Kreek MJ: Abnormal metyrapone tests during cocaine abstinence; in Harris LS (ed): Problems of Drug Dependence, 1997. Proc 59th Annu Sci Meet College on Problems of Drug Dependence, NIDA Res Mon Ser Washington, US Government Printing Office, in press.
14.
Kreek MJ: Opioid receptors: Some perspectives from early studies on their role in normal physiology, stress responsivity and in specific addictive diseases. Neurochem Res 1996;21:1469–1488.
15.
Koob GF, Le Moal M: Drug abuse: Hedonic homeostatic dysregulation. Science 1997;278:52–58.
16.
Piazza PV, Demenier J-M, Le Moal M, Simon H: Factors that predict individual vulnerability to amphetamine self-administration. Science 1989;245:1511–1514.
17.
Erb S, Shaham Y, Stewart J: Stress reinstates cocaine-seeking behavior after prolonged extinction and a drug-free period. Psychopharmacology 1996;128:408–412.
18.
Piazza PV, Le Moal M: Glucocorticoids as biological substrate of reward: Physiological and pathophysiological implications. Brain Res Rev 1997;25:259–372.
19.
Dallman MF, Akana SF, Scribner KA, Bradbury MJ, Walker CD, Strack AM, Cascio CS: Stress, feedback and facilitation in the hypothalamo-pituitary-adrenal axis. J Neuroendocrinol 1992;4:517–526.
20.
Herman JP, Adams D, Previtt C: Regulatory changes in neuroendocrine stress-intergrative circuitry produced by a variable stress paradigm. Neuroendocrinology 1995;61:180–190.
21.
Armario A, Hidalgo J, Giralt M: Evidence that the pituitary-adrenal axis does not cross-adapt to stressors: comparison to other physiological variables. Neuroendocrinology 1988;47:263–267.
22.
Marti O, Gavalda A, Gomez F, Armario A: Direct evidence for chronic stress-induced facilitation of the adrenocortical response to a novel acute stressor. Neuroendocrinology 1994;60:1–7.
23.
Gomez F, Lahmame A, De Kloet ER, Armario A: Hypothalamic-pituitary-adrenal response to chronic stress in five inbred rat strains. Differential responses are mainly located at the adrenocortical level. Neuroendocrinology 1996;63:327–337.
24.
McEwen BS: Protective and damaging effects of stress mediators. New Engl J Med 1998;338:171–179.
25.
Levy AD, Li Q, Alvarez Sanz MC, Rittenhouse PA, Kerr JE, Van de Kar LD: Neuroendocrine responses to cocaine do not exhibit sensitization following repeated cocaine exposure. Life Sci 1992;51:887–897.
26.
Torres G, Rivier C: Cocaine-induced stimulation of the rat hypothalamic-pituitary-adrenal axis is progressively attenuated following hourly-interval regimens of the drug. Life Sci 1992;51:1041–1048.
27.
Schmidt ED, Tilders FJ, Janszen AW, Binnekade R, De Vries TJ, Schoffelmeer AN: Intermittent cocaine exposure causes delayed and long-lasting sensitization of cocaine-induced ACTH secretion in rats. Eur J Pharmacol 1995;285:317–321.
28.
Zhou Y, Spangler R, LaForge KS, Maggos CE, Kreek MJ: Corticotropin-releasing factor and CRF-R1 mRNA in rat brain and pituitary during ‘binge’ pattern cocaine administration and withdrawal. J Pharmacol Exp Ther 1996;279:351–358.
29.
Zhou Y, Spangler R, Maggos CE, LaForge KS, Ho A, Kreek MJ: Effects of cocaine withdrawal conditions on POMC mRNA in rat anterior piruitary; in Harris LS (ed): Problems of Drug Dependence, 1996. Proceedings of the 59th Annual Scientific Meeting of the College on Problems of Drug Dependence. NIDA Res Mon Ser. Washington, US Government Printing Office, 1997, vol 174, p 148.
30.
Sarnyai Z, Bíró É, Gardi J, Vecsernyés M, Julesz J, Telegdy G: Brain corticotropin-releasing factor (CRF) mediates ‘anxiety-like’ behavior induced by cocaine withdrawal in rats. Brain Res 1995;675:69–77.
31.
Lucas LR, Schlussman SD, Ho A, McEwen BS, Kreek MJ: Novelty-induced locomotor activity in Long-Evans rats pre- and post-chronic ‘binge’-pattern cocaine treatment. Neurosci Lett 1997;237:25–28.
32.
Kreek MJ: Opiates, opioids and addiction. Mol Psychiatry 1996;1:232–254.
33.
Spangler R, Unterwald EM, Kreek MJ: ‘Binge’ cocaine administration induces a sustained increase of prodynorphin mRNA in rat caudate-putamen. Mol Brain Res 1993;19:323–327.
34.
Unterwald EM, Horne-King J, Kreek MJ: Chronic cocaine alters brain mu opioid receptors. Brain Res 1992;584:314–318.
35.
Magarinos AM, McEwen BS: Stress-induced atrophy of apical dendrites of hippocampal CA3c neurons: comparison of stressors. Neuroscience 1995;69:83–88.
36.
Balopole DC, Hansult CD, Dorph D: Effect of cocaine on food intake in rats. Psychopharmacology 1979;64:121–122.
37.
Spector S, Traver J, Berkowitz B: Effects of drugs and physiological factors in the disposition of catecholamines in blood vessels. Pharmacol Rev 1972;24:191–202.
38.
Berul CI and Harclerode JE: Effects of cocaine hydrochloride on the male reproductive system. Life Sci 1989;45:91–95.
39.
Budziszewska B, Jaworska-Feil L, Lason W: The effect of repeated amphetamine and cocaine administration on adrenal, gonadal and thyroid hormone levels in the rat plasma. Exp Clin Endocrinol Diabetes 1996;104:334–338.
40.
Rivest S and Rivier C: The role of corticotropin-releasing factor and interleukin-1 in the regulation of neurons controlling reproductive functions. Endocr Rev 1995;16:177–199.
41.
Barroso-Moguel R, Mendez-Armenta M, Villeda-Hernandez J: Testicular lesions by chronic administration of cocaine in rats. J Appl Toxicol 1994;14:37–41.
42.
Kirby RJ and Petchkovsky L: Chronic administration of cocaine: Effects on defecation and adrenal hypertrophy in the rat. Neuropharmacology 1973;12:1001–1003.
43.
Borowsky B, Kuhn CM: Chronic cocaine administration sensitizes behavioral but not neuroendocrine responses. Brain Res 1991;543:301–306.
44.
Levy AD, Rittenhouse PA, Li Q, Yracheta J, Kunimoto K, Van de Kar LD: Influence of repeated cocaine exposure on the endocrine and behavioral responses to stress in rats. Psychopharmacology (Berl) 1994;113:547–554.
45.
Markou A, Kosten TR, Koob GF: Neurobiological similarities in depression and drug dependence: A self-medication hypothesis. Neuropsychopharmacology 1998;18:135–174.
46.
Sarnyai Z, Bíró É, Gardi J, Vecsernyés M, Julesz J, Telegdy G: Acute cocaine administration alters corticotropin-releasing factor (CRF)-like immunoreactivity in different rat brain regions. Brain Res 1993;616:315–319.
47.
Gardi J, Bíró É, Sarnyai Z, Vecsernyés M, Julesz J, Telegdy G: Time-dependent alterations of corticotropin-releasing factor (CRF)-like immunoreactivity in different brain regions after acute cocaine administration in rats. Neuropeptides 1997;31:15–18.
48.
Blanchard DC, Spencer RL, Weiss SM, Blanchard RJ, McEwen BS, Sakai RR: Visible burrow system as a model of chronic social stress: Behavioral and neuroendocrine correlates. Psychoneuroendocrinology 1995;20:117–134.
49.
Cam GR and Bassett JR: Effect of prolonged exposure to nicotine and stress on the pituitary-adrenocortical response: The possibility of cross-adaptation. Pharmacol Biochem Behav 1984;20:221–226.
50.
Spencer RL, McEwen BS: Adaptation of the hypothalamic-pituitary-adrenal axis to chronic ethanol stress. Neuroendocrinology 1990;52:481–489.
51.
Li HY, Ericsson A, Sawchenko PE: Distinct mechanisms underlie activation of hypothalamic neurosecretory neurons and their medullary cathecholaminergic afferents in categorically different stress paradigms. Proc Natl Acad Sci USA 1996;93:2359–2364.
52.
Li HY, Sawchenko PE: Hypothalamic efferent neurons and extended circuitries activated in ‘neurogenic’ stress: A comparison of footshock effects exerted acutely, chronically, and in animals with controlled glucocorticoid levels. J Comp Neurol 1998;393:244–266.
53.
Calogero AE, Gallucci WT, Kling MA, Chrousos GP, Gold PW: Cocaine stimulates rat hypothalamic corticotropin-releasing hormone secretion in vitro. Brain Res 1989;505:7–11.
54.
Budziszewska B, Leskiewicz M, Jaworska-Feil L, Lason W: Repeated cocaine administration down-regulates glucocorticoid receptors in the rat brain cortex and hippocampus. Pol J Pharmacol 1996;48:575–581.
55.
Aouizerate B, Schluger JH, Perret G, McClary K, Ho A, Piazza PV, Kreek MJ: Enhanced sensitivity to negative glucocorticoid feedback in methadone patients with ongoing cocaine dependence; in Problems of Drug Dependence, 1998. Proc 60th Annu Sci Meet, in press.
56.
Ho A, Schlussman SD, Zhou Y, Maggos CE, Spangler R, Kreek MJ: Withdrawal from chronic binge pattern cocaine in the Fischer rat: The role of expectancy and conditioning; in Harris LS (ed): Problems of Drug Dependence, 1996. Proc 58th Annu Meet College on Problems of Drug Dependence. NIDA Res Monogr 1997;174:175.
57.
Boudaba C, Szabó K, Tasker JG: Physiological mapping of local inhibitory inputs to the hypothalamic paraventricular nucleus. J Neurosci 1996;16:7151–7160.
1998
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.